Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Mounjaro is the brand name for tirzepatide for weight loss
The results paved the way for liraglutide, branded as Saxenda, to be approved in the US as a once-a-day subcutaneous injection in December 2014 and in Europe in 2015 for the treatment of chronic weight management combined with a reduced calorie diet and increased physical exercise (Molteni, Chen)
Weight Loss Results at 48 Weeks: Key Percentage Findings At 48 weeks, the 12 mg retatrutide dose produced a mean body weight reduction of approximately 24.2%, compared with approximately 2.1% in the placebo group, with weight loss still ongoing at trial end
If you're administering shots yourself, always use the subcutaneous method
Vomiting and diarrhea can lead to dehydration, which in turn may raise the risk of kidney complications particularly in older adults and people with existing kidney disease
